Tonix Pharmaceuticals Holding Corp.Tonix Pharmaceuticals Holding Corp.Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.

No trades
See on Supercharts
Market capitalization
‪12.33 M‬USD
−8.6199USD
‪−116.66 M‬USD
‪7.77 M‬USD
‪84.49 M‬
Beta (1Y)
2.22

About Tonix Pharmaceuticals Holding Corp.

CEO
Seth Lederman
Headquarters
Chatham
Employees (FY)
103
Founded
2007
ISIN
US8902608541
FIGI
BBG000LG8XM5
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TNXP is 0.15 USD — it has decreased by 10.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tonix Pharmaceuticals Holding Corp. stocks are traded under the ticker TNXP.
Tonix Pharmaceuticals Holding Corp. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Tonix Pharmaceuticals Holding Corp. has a max estimate of 6.00 USD and a min estimate of 1.50 USD.
TNXP earnings for the last quarter are −1.83 USD whereas the estimation was −1.49 USD which accounts for −22.82% surprise. Estimated earnings for the next quarter are −1.46 USD. See more details about Tonix Pharmaceuticals Holding Corp. earnings.
Tonix Pharmaceuticals Holding Corp. revenue for the last quarter amounts to ‪3.99 M‬ USD despite the estimated figure of ‪5.80 M‬ USD. In the next quarter revenue is expected to reach ‪5.17 M‬ USD.
Yes, you can track Tonix Pharmaceuticals Holding Corp. financials in yearly and quarterly reports right on TradingView.
Like other stocks, TNXP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tonix Pharmaceuticals Holding Corp. stock right from TradingView charts — choose your broker and connect to your account.
TNXP reached its all-time high on Feb 8, 2012 with the price of 8240000.00 USD, and its all-time low was 0.16 USD and was reached on Apr 11, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 103.00 employees. See our rating of the largest employees — is Tonix Pharmaceuticals Holding Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Tonix Pharmaceuticals Holding Corp. EBITDA is ‪−114.12 M‬ USD, and current EBITDA margin is ‪−1.47 K‬%. See more stats in Tonix Pharmaceuticals Holding Corp. financial statements.